rebellious glp 1 GLP-1 Support Whether youre cutting GLP-1 Drugs and Eating Disorders:

In the SYNERGY-NASH trial, a phase 2 study involving participants with metabolic dysfunctionassociated steatohepatitis (MASH) and moderate or severe fibrosis, treatment with tirzepatide for 52 weeks was more effective than placebo in achieving resolution of MASH without worsening fibrosis [146]

a 21% lower likelihood of emergency department visits

Do not use if you or your family have a history of a type of thyroid cancer called MTC or MEN 2

Both medications can lead to significant weight loss but come with specific side effects

Now, a pilot program at the Open Doors transitional home, a Rhode Island non-profit, has offered the drugs to 18 of its residents, many of whom say the GLP-1s, along with the other supports offered there, have changed their lives

Results of a consensus conference